OGEN Stock: The Covid Vaccine News That Has Oragenics Shooting Higher Today


Oragenics (NYSEAMERICAN:OGEN) stock is surging higher on Tuesday following news that the company is developing a new vaccine for the novel coronavirus.

A bunch of glass vials of SARS-CoV-2 vaccines representing OGEN stock.

Source: Shutterstock

According to a press release, Oragenics has signed a licensing agreement with the National Research Council of Canada (NRC) to develop the coronavirus vaccine. It plans to use this data in combination with elements found in its Terra CoV-2 vaccine to create a platform for the new vaccine.

Oragenics notes that it will be able to rapidly develop its COVID-19 vaccine. That is thanks to its platform allowing for “high-yield production of spike protein antigens for existing and emerging variants.”

This should allow Oragenics to create vaccines within six to eight weeks of spike gene sequence availability. That’s a massive improvement over the traditional six to nine months it takes to produce those cell lines.

Frederick W. Telling, Ph.D., executive chairman of Oragenics, said this about the news boosting OGEN stock today.

“With respect to our potential future competitive positioning against currently available SARS-CoV-2 vaccines, we believe the licensed technologies will improve development speed, while the ability to rapidly engineer new vaccine antigens will permit us to quickly address new variants as they arise.”

OGEN stock is seeing major movement today following its coronavirus vaccine news. This has more than 111 million shares of the stock changing hands as of this writing. To put that in perspective, the company’s daily average trading volume is about 2.2 million shares.

OGEN stock was up 61.6% as of Tuesday morning and is up 96.2% since the start of the year.

We’ve got plenty of other news for investors to check out below!

InvestorPlace offers the latest news for the stock market with our daily coverage. For today, that includes big tech earnings coming out today, the biggest pre-market stock movers, as well as yesterday’s important stories. You can check out all of these at the following links!

More Tuesday Stock Market News

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. Read More: Penny Stocks — How to Profit Without Getting Scammed

Article printed from InvestorPlace Media, https://investorplace.com/2021/07/ogen-stock-the-covid-vaccine-news-that-has-oragenics-shooting-higher-today/.

©2023 InvestorPlace Media, LLC